Skip to main content

Table 2 The TGF-β information and results of the included studies

From: Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis

 

Gene subtype

High expression (%)

Test sample

Test content

Test method

Analytic method

Outcome

HR for OS

95% CI HR for OS

HR for DFS

95% CI HR for DFS

Zhu J

TGF-β1

53.0

Tissue

Protein

IHC

Multivariate

OS

3.33

1.41–7.87

NR

NR

Chun HK

TGF-β1

14.9

Tissue

Protein

IHC

Multivariate

DFS

NR

NR

9.19

1.26–67.20

Langenskiöld M

TGF-β1

NR

Tissue

Protein

ELISA

Multivariate

OS

1.00

0.99–1.01

NR

NR

Uhlmann ME

TGF-β

25.2

Tissue

mRNA

PCR

Surv curve

OS

1.13

0.42–3.03

NR

NR

Lampropoulos P

TGF-β

71.3

Tissue

Protein

IHC

Multivariate

OS

4.68

2.09–10.48

NR

NR

Li X

TGF-β1

70.7

Tissue

Protein

IHC

Univariate

OS, DFS

0.75

0.48–1.16

0.81

0.55–1.20

Khanh do T

TGF-β1

55.3

Tissue

Protein

IHC

Multivariate

OS, RFS

1.62

0.74–3.56

1.46

0.74–2.87

Wincewicz A

TGF-β1

83.3

Tissue

Protein

IHC

Survival curve

DFS

NR

NR

1.00

0.93–1.07

Gulubova M

TGF-β1

25.4

Tissue

Protein

IHC

Surv curve

OS

1.35

0.82–2.23

NR

NR

Bellone G

TGF-β1

NR

Serum

Protein

ELISA

Multivariate

DFS

NR

NR

1.11

1.03–1.20

Tsamandas AC

TGF-β1

79.0

Tissue

Protein

IHC

Multivariate

OS, DFS

1.55

1.33–3.08

1.09a

0.27–4.4

Robson H

TGF-β1

58.3

Tissue

Protein

IHC

Surv curve

OS

0.56

0.15–2.14

NR

NR

Friedman E

TGF-β1

58.8

Tissue

Protein

PCR

Surv curve

DFS

NR

NR

3.33

0.47–23.43

  1. DFS disease-free survival, ELISA enzyme-linked immunosorbent assay, IHC Immunohistochemistry, Multivariate Multivariate survival analyses, NR not reported, OS overall survival, PCR Polymerase chain reaction, RFS recurrence-free survival (which was used as DFS), Surv curve survival curve, Univariate Univariate survival analyses
  2. a:the result was analysed by the Univariate method